Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Michael Wang
Jul 25, 2024, 14:02 |
Insight
Erman Akkus: Should up-front SRS be added to TKI in brain metastatic EGFR/ALK positive NSCLC?
Erman Akkus, Medical Oncologist at Ankara University, shared a paper by Luke R.G. Pike et al. on…
Jul 24, 2024, 13:13 |
Blog
Earle Burgess: Bipolar androgen therapy for advanced prostate cancer
Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared on LinkedIn: "Bipolar androgen therapy…
Jul 19, 2024, 22:57 |
Insight
Andrew Armstrong: WNT pathway alterations in prostate cancer
Andrew Armstrong, Professor of Medicine, Surgery, Pharmacology and Cancer Biology at the Duke Cancer Institute,…
Jul 18, 2024, 10:41 |
Insight
Stephen Liu: Can we predict risk of immune related toxicity with immunotherapy for NSCLC
Stephen Liu shared a post on X about a recent paper by Fei Xing et…
Jul 16, 2024, 13:55 |
Blog
5 papers to read suggested by Vivek Subbiah
We are presenting articles suggested by Vivek Subbiah: 1.'Pancreatic Cancer Surveillance and Survival of High-Risk…
Jul 14, 2024, 22:08 |
Blog
Jessie Guo: G6PD is essential for KL but not KP lung tumorigenesis
Jessie Guo, Associate Professor at Rutgers Cancer Institute of New Jersey, shared on X: "Check…
Jul 7, 2024, 10:40 |
Insight
Distinction of AA vs inherited BM failure syndromes
Naveen Pemmaraju shared on X: "Our article just out in Clinical Lymphoma Myeloma Leukemia (CLML)…
Jul 6, 2024, 11:51 |
Insight
10 Papers Suggested Today By Wafik S. El-Deiry
Wafik S. El-Deiry shared a few must-reads papers on X: 1. Targeting MYC effector functions…
Jul 1, 2024, 23:51 |
Insight
Piotr Wysocki: Neoadjuvant therapy for renal-cell cancer patients is still in its infancy, unlike in melanoma
Piotr Wysocki recently posted on LinkedIn: "The PROSPER ECOG-ACRIN EA8143 study (published online in Lancet…
May 17, 2024, 16:25 |
Blog
Joe Lennerz: Cover Story in Cancer Cell
Joe Lennerz, Chief Scientific Officer at BostonGene, shared on LinkedIn: "Cover Story in Cancer Cell.…
1
2
3
4
5
All:
42
Posts:
31 - 40
ASTRO24: 20 Posts Not To Miss From Day 1
Fran Drescher and Uterine Cancer: How She Went Against, How She Survived, and More
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube